Find Events
or
Drug Repositioning and the 505(b)(2) Application: <br><i>A Step-by-Step Approach to a Fuller, More Profitable Pipeline</i>
Registration
Audio CD/Transcript - Dec. 12, 2007 <p>
The Audio CD/Transcript will be shipped the week of Jan. 7, 2008.
</p>
$397.00
Audio CD/Transcript - Dec. 12, 2007 <p>
The Audio CD/Transcript will be shipped the week of Jan. 7, 2008.
</p>
$397.00
When
Event Description
Listen closely while Kenneth Phelps, president and CEO of Camargo Pharmaceutical Services, compares the various new drug approval applications and shows you when a 505(b)(2) is the best choice.